RT Generic
T1 Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic Reply
A1 Mendez-Bailon, Manuel
A1 Gomez, Javier Aza na
A1 Belmonte, Luis Perez
PB Elsevier espana slu
PB Elsevier
SN 0025-7753
YR 2022
FD 2022-10-26
LK http://hdl.handle.net/10668/22378
UL http://hdl.handle.net/10668/22378
LA es
NO Kow CS, Ramachandram DS, Hasan SS. Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic. Med Clin (Barc). 2022 Nov 11;159(9):e61
DS RISalud
RD Apr 11, 2025